Piperidine-MO-1 |
| Catalog No.GC31183 |
Piperidina-MO-1 es un modulador del receptor de dopamina extraÍdo de la patente WO/2005/121087A1, compuesto ejemplo 2; exhibe un ED50 de 68 μmol/kg en el aumento de DOPAC en el cuerpo estriado de rata.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 871351-61-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Piperidine-MO-1 is a modulator of dopamine receptor extracted from patent WO/2005/121087A1, compound example 2; exhibits an ED50 of 68 μmol/kg on increase of DOPAC in the rat striatum.
[1]. WO/2005/121087A1
Average Rating: 5 (Based on Reviews and 2 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *